至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region.

J. Biol. Chem.. 2015-03; 
LarabeeJason L,KrumholzAleze,HuntJonathan J,LanisJordi M,BallardJim
Products/Services Used Details Operation
Peptide Synthesis … For examining the potential linear epitope (positions 1773–1780), this blocking assay was performed using a 19-amino acid peptide spanning residues 1769–1787 of TcdB 012 This peptide was synthesized and purified to 95% by GenScript (Piscataway, NJ) Cross-linking … Get A Quote

摘要

The sequence, activity, and antigenicity of TcdB varies between different strains of Clostridium difficile. As a result, ribotype-specific forms of TcdB exhibit different toxicities and are not strongly cross-neutralized. Using a combination of biochemical and immunological approaches, we compared two important variants of TcdB (TcdB012 and TcdB027) to identify the mechanisms through which sequence differences alter epitopes and activity of the toxin. These analyses led to the discovery of a critical variation in the 1753-1851 (B2') region of TcdB, which affects the exposure of neutralizing epitopes in the toxin. Sequence comparisons found that the B2' region exhibits only 77% identity and is the most... More

关键词

Antibody,Bacterial Pathogenesis,Bacterial Toxin,Clostridium difficile,Infectious Disease,Ribotype 027,TcdB,T